Guilisan, Sophia E.
HRN: 23-53-91 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/18/2026
03/25/2026
IV
680mg
Q6
URTI
Checking Initial Appropriateness